Cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected injection drug users: A randomized controlled trial.
- 1 June 2012
- journal article
- research article
- Published by American Psychological Association (APA) in Journal of Consulting and Clinical Psychology
- Vol. 80 (3), 404-415
- https://doi.org/10.1037/a0028208
Abstract
Depression and substance use, the most common comorbidities with HIV, are both associated with poor treatment adherence. Injection drug users comprise a substantial portion of individuals with HIV in the United States and globally. The present study tested cognitive behavioral therapy for adherence and depression (CBT-AD) in patients with HIV and depression in active substance abuse treatment for injection drug use. This is a 2-arm, randomized controlled trial (N = 89) comparing CBT-AD with enhanced treatment as usual (ETAU). Analyses were conducted for two time-frames: (a) baseline to post-treatment and (b) post-treatment to follow-up at 3 and 6 months after intervention discontinuation. At post-treatment, the CBT-AD condition showed significantly greater improvement than ETAU in MEMS (electronic pill cap) based adherence, γslope = 0.8873, t(86) = 2.38, p = .02; dGMA-raw = 0.64, and depression, assessed by blinded assessor: Mongomery-Asberg Depression Rating Scale, F(1, 79) = 6.52, p < .01, d = 0.55; clinical global impression, F(1, 79) = 14.77, p < .001, d = 0.85. After treatment discontinuation, depression gains were maintained, but adherence gains were not. Viral load did not differ across condition; however, the CBT-AD condition had significant improvements in CD4 cell counts over time compared with ETAU, γslope = 2.09, t(76) = 2.20, p = .03, dGMA-raw = 0.60. In patients managing multiple challenges including HIV, depression, substance dependence, and adherence, CBT-AD is a useful way to integrate treatment of depression with an adherence intervention. Continued adherence counseling is likely needed, however, to maintain or augment adherence gains in this population.Keywords
Funding Information
- National Institute on Drug Abuse (Grant R01DA018603)
This publication has 46 references indexed in Scilit:
- Effect sizes for growth-modeling analysis for controlled clinical trials in the same metric as for classical analysis.Psychological Methods, 2009
- A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected individuals.Health Psychology, 2009
- Strategies for promoting adherence to antiretroviral therapy: a review of the literature.Current Infectious Disease Reports, 2008
- HIV prevalence estimates--United States, 2006.2008
- Repeated Measures Longitudinal Analyses of HIV Virologic Response as a Function of Percent Adherence, Dose Timing, Genotypic Sensitivity, and Other FactorsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2006
- HIV disease progression: depression, stress, and possible mechanismsBiological Psychiatry, 2003
- Electronic monitoring: Adherence assessment or intervention?HIV Research & Clinical Practice, 2002
- Detrimental Effects of Continued Illicit Drug Use on the Treatment of HIV-1 InfectionJAIDS Journal of Acquired Immune Deficiency Syndromes, 2001
- Meta-Analysis of the Relationship Between HIV Infection and Risk for Depressive DisordersAmerican Journal of Psychiatry, 2001
- Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease.Health Psychology, 2000